Neurologia最新文献

筛选
英文 中文
Microorganismos relacionados con un mayor riesgo de presentar la enfermedad de Parkinson 与患帕金森氏症风险增加有关的微生物
IF 3.9 4区 医学
Neurologia Pub Date : 2023-09-01 DOI: 10.1016/j.nrl.2020.08.020
E. Fernández-Espejo
{"title":"Microorganismos relacionados con un mayor riesgo de presentar la enfermedad de Parkinson","authors":"E. Fernández-Espejo","doi":"10.1016/j.nrl.2020.08.020","DOIUrl":"https://doi.org/10.1016/j.nrl.2020.08.020","url":null,"abstract":"<div><p>Parkinson's disease is a neurodegenerative disorder that affects more than 7 million people worldwide. Its aetiology is unknown, although the hypothesis of a genetic susceptibility to environmental agents is accepted. These environmental agents include fungi, bacteria, and viruses. Three microorganisms are directly associated with a significantly increased risk of developing Parkinson's disease: the fungal genus <em>Malassezia</em>, the bacterium <em>Helicobacter pylori</em>, and the hepatitis C virus. If the host is vulnerable due to genetic susceptibility or immune weakness, these microorganisms can access and infect the nervous system, causing chronic neuroinflammation with neurodegeneration. Other microorganisms show an epidemiological association with the disease, including the influenza type A, Japanese encephalitis type B, St Louis, and West Nile viruses. These viruses can affect the nervous system, causing encephalitis, which can result in parkinsonism. This article reviews the role of all these microorganisms in Parkinson's disease.</p></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 7","pages":"Pages 495-503"},"PeriodicalIF":3.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.nrl.2020.08.020","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50180340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Espectro de neuromielitis óptica: ¿seropositivo para la anticuaporina es una entidad diferente de los pacientes que son seronegativos? Una perspectiva de Colombia 视神经脊髓炎谱系:抗华波林血清阳性与血清阴性患者是否有不同的实体?哥伦比亚透视
IF 3.9 4区 医学
Neurologia Pub Date : 2023-09-01 DOI: 10.1016/j.nrl.2020.08.018
P.A. Ortiz Salas , M. Gaviria Carrillo , G.A. Cortés Bernal , K. Moreno Medina , L.F. Roa , J.H. Rodríguez Quintana
{"title":"Espectro de neuromielitis óptica: ¿seropositivo para la anticuaporina es una entidad diferente de los pacientes que son seronegativos? Una perspectiva de Colombia","authors":"P.A. Ortiz Salas ,&nbsp;M. Gaviria Carrillo ,&nbsp;G.A. Cortés Bernal ,&nbsp;K. Moreno Medina ,&nbsp;L.F. Roa ,&nbsp;J.H. Rodríguez Quintana","doi":"10.1016/j.nrl.2020.08.018","DOIUrl":"https://doi.org/10.1016/j.nrl.2020.08.018","url":null,"abstract":"<div><h3>Introduction</h3><p>Neuromyelitis optica (NMO) is an inflammatory disease of the central nervous system characterised by attacks of optic neuritis and longitudinally extensive transverse myelitis. The discovery of anti–aquaporin-4 (anti-AQP4) antibodies and specific brain MRI findings as diagnostic biomarkers have enabled the recognition of a broader and more detailed clinical phenotype, known as neuromyelitis optica spectrum disorder (NMOSD).</p></div><div><h3>Objective</h3><p>This study aimed to determine the demographic and clinical characteristics of patients with NMO/NMOSD with and without seropositivity for anti-AQP4 antibodies, in 2 quaternary-level hospitals in Bogotá.</p></div><div><h3>Methods</h3><p>Our study included patients &gt; 18 years of age and diagnosed with NMO/NMOSD and for whom imaging and serology results were available, assessed between 2013 and 2017 at the neurology departments of hospitals providing highly complex care. Demographic, clinical, and imaging data were gathered and compared in patients with and without seropositivity for anti-AQP4 antibodies.</p></div><div><h3>Results</h3><p>The sample included 35 patients with NMO/NMOSD; the median age of onset was 46.5 years (P25-P75, 34.2-54.0); most patients had sensory (n = 25) and motor manifestations (n = 26), and a concomitant autoimmune disease was identified in 6. Twenty patients were seropositive for anti-AQP4 antibodies. Only age and presence of optic nerve involvement showed statistically significant differences between groups (p = .03).</p></div><div><h3>Conclusions</h3><p>Clinical, imaging, and laboratory variables showed no major differences between patients with and without anti-AQP4 antibodies, with the exception of age of onset and presence of optic nerve involvement (uni- or bilateral); these factors should be studied in greater detail in larger populations.</p></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 7","pages":"Pages 504-510"},"PeriodicalIF":3.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.nrl.2020.08.018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50180341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Environmental exposure to pesticides and Amyotrophic Lateral Sclerosis in the South of Spain 西班牙南部农药环境暴露与肌萎缩侧索硬化症
IF 3.9 4区 医学
Neurologia Pub Date : 2023-09-01 DOI: 10.1016/j.nrl.2021.01.013
S. Bermudo Fuenmayor , P.J. Serrano Castro , P. Quiroga Subirana , S. López Palmero , M. Requena Mullor , T. Parrón Carreño
{"title":"Environmental exposure to pesticides and Amyotrophic Lateral Sclerosis in the South of Spain","authors":"S. Bermudo Fuenmayor ,&nbsp;P.J. Serrano Castro ,&nbsp;P. Quiroga Subirana ,&nbsp;S. López Palmero ,&nbsp;M. Requena Mullor ,&nbsp;T. Parrón Carreño","doi":"10.1016/j.nrl.2021.01.013","DOIUrl":"10.1016/j.nrl.2021.01.013","url":null,"abstract":"<div><h3>Objective</h3><p>To determine if there is a relationship between environmental exposure to pesticides and the prevalence of Amyotrophic Lateral Sclerosis (ALS) in Andalusia.</p></div><div><h3>Method</h3><p>We carried out a case–control study using the logistic regression method to verify the relationship between the prevalence of ALS in the area exposed to pesticides versus the unexposed area, through the Odds Ratio statistical test.</p></div><div><h3>Results</h3><p>The study population consisted of 519 individuals diagnosed with ALS between January 2016 and December 2018 according to the CMBD (Minimum Basic Data Set) as cases. In the control group, we have 8,384,083 individuals obtained from data from the National Institute of Statistics (INE). The Odds Ratio (OR) was used as a measure of association between cases and controls, obtaining an OR between 0.76 and 1.08 for the confidence interval of the CI (95%).</p></div><div><h3>Conclusions</h3><p>Despite the existence of various studies that suggest a possible association between environmental exposure to pesticides and the risk of Amyotrophic Lateral Sclerosis, our analysis of the Andalusian population did not find significant evidence of this association.</p></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 7","pages":"Pages 447-452"},"PeriodicalIF":3.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.nrl.2021.01.013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25520246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
miR-146a aggravates cognitive impairment and Alzheimer disease-like pathology by triggering oxidative stress through MAPK signaling miR-146a通过MAPK信号触发氧化应激,加重认知障碍和阿尔茨海默病样病理
IF 3.9 4区 医学
Neurologia Pub Date : 2023-09-01 DOI: 10.1016/j.nrl.2020.12.006
H. Zhan-qiang , Q. Hai-hua , Z. Chi , W. Miao , Z. Cui , L. Zi-yin , H. Jing , W. Yi-wei
{"title":"miR-146a aggravates cognitive impairment and Alzheimer disease-like pathology by triggering oxidative stress through MAPK signaling","authors":"H. Zhan-qiang ,&nbsp;Q. Hai-hua ,&nbsp;Z. Chi ,&nbsp;W. Miao ,&nbsp;Z. Cui ,&nbsp;L. Zi-yin ,&nbsp;H. Jing ,&nbsp;W. Yi-wei","doi":"10.1016/j.nrl.2020.12.006","DOIUrl":"10.1016/j.nrl.2020.12.006","url":null,"abstract":"<div><h3>Introduction</h3><p>Mir-146a-5p has been widely recognized as a critical regulatory element in the immune response. However, recent studies have shown that miR-146a-5p may also be involved in the development of Alzheimer disease (AD). Regrettably, the related mechanisms are poorly understood. Here, we investigated the effects of miR-146a in mice models and SH-SY5Y cells treated with amyloid β (Aβ)<sub>1–42</sub>.</p></div><div><h3>Methods</h3><p>To create a model of AD, SH-SY5Y cells were treated with Aβ<sub>1–42</sub> and mice received intracerebroventricular injections of Aβ<sub>1–42</sub>. Then, the transcriptional levels of miR-146a were estimated by real-time PCR. We transiently transfected the miR-146a-5p mimic/inhibitor into cells and mice to study the role of miR-146a. The role of signaling pathways including p38 and reactive oxygen species (ROS) was studied by using specific inhibitors. Aβ and amyloid-beta precursor protein (APP)levels were measured by immunoblotting. Furthermore, Aβ expression was analyzed by immunofluorescence and histochemical examinations.</p></div><div><h3>Results</h3><p>Aβ<sub>1–42</sub>-stimulated SH-SY5Y cells displayed increased transcriptional levels of miR-146a and APP. Moreover, the p38 MAPK signaling pathway and ROS production were activated upon stimulation with a miR-146a-5p mimic. However, treatment with a miR-146a-5p inhibitor decreased the levels of APP, ROS, and p-p38 MAPK. A similar phenomenon was also observed in the animals treated with Aβ<sub>1–42</sub>, in which miR-146a upregulation increased the expression of Aβ, p-p38, and ROS, while the inhibition of miR-146a had the opposite effect. This suggests that miR-146a increases Aβ deposition and ROS accumulation via the p-p38 signaling pathway.</p></div><div><h3>Conclusions</h3><p>Our research demonstrates that miR-146a-5pa increases Aβ deposition by triggering oxidative stress through activation of MAPK signaling.</p></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 7","pages":"Pages 486-494"},"PeriodicalIF":3.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.nrl.2020.12.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25475066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Leucoencefalopatía multifocal progresiva: a propósito de un caso que precede al diagnóstico de un linfoma sistémico 进行性多灶性脑白质病:关于系统性淋巴瘤诊断前的病例
IF 3.9 4区 医学
Neurologia Pub Date : 2023-09-01 DOI: 10.1016/j.nrl.2022.07.005
A. Ostolaza , I. Gastón , J. Marta , I. Ormazabal , M.E. Erro
{"title":"Leucoencefalopatía multifocal progresiva: a propósito de un caso que precede al diagnóstico de un linfoma sistémico","authors":"A. Ostolaza ,&nbsp;I. Gastón ,&nbsp;J. Marta ,&nbsp;I. Ormazabal ,&nbsp;M.E. Erro","doi":"10.1016/j.nrl.2022.07.005","DOIUrl":"10.1016/j.nrl.2022.07.005","url":null,"abstract":"","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 7","pages":"Pages 511-513"},"PeriodicalIF":3.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42778018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-late-onset neutropaenia following treatment of multiple sclerosis with ocrelizumab ocrelizumab治疗多发性硬化症后非迟发性中性粒细胞增多症
IF 3.9 4区 医学
Neurologia Pub Date : 2023-09-01 DOI: 10.1016/j.nrl.2021.01.010
E.M. Alba Suárez , A. Tallón Barranco , I. Puertas Muñoz , B. Chamorro Hernández , Á. Robles Marhuenda
{"title":"Non-late-onset neutropaenia following treatment of multiple sclerosis with ocrelizumab","authors":"E.M. Alba Suárez ,&nbsp;A. Tallón Barranco ,&nbsp;I. Puertas Muñoz ,&nbsp;B. Chamorro Hernández ,&nbsp;Á. Robles Marhuenda","doi":"10.1016/j.nrl.2021.01.010","DOIUrl":"10.1016/j.nrl.2021.01.010","url":null,"abstract":"<div><p>Late-onset neutropaenia is defined as an absolute neutrophil count of &lt;1.5<!--> <!-->×<!--> <!-->10<sup>3</sup> <!-->cells/μL starting<!--> <!-->&gt;<!--> <!-->4 weeks after the last dose of rituximab, in the absence of other identifiable causes.</p><p>Late-onset neutropaenia is a rare adverse reaction to rituximab (observed in approximately 5% of patients). Rheumatic diseases constitute the main indication for rituximab; in these patients, neutropaenia appears after a mean of<!--> <!-->&gt;<!--> <!-->28 days.</p><p>Ocrelizumab is another monoclonal antibody that binds to CD20 (a glycosylated phosphoprotein mainly expressed on the membranes of B-lymphocytes); in January 2018, it was approved for the treatment of relapsing-remitting and primary progressive multiple sclerosis.</p><p>We present a case of neutropaenia following intravenous infusion of ocrelizumab in a patient with primary progressive multiple sclerosis who presented with neutropaenic fever, herpetic stomatitis, and ecthyma gangrenosum only 20 days after infusion.</p></div>","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"38 7","pages":"Pages 463-466"},"PeriodicalIF":3.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.nrl.2021.01.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25494753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Basilar web y fenestración basilar; a propósito de un caso
IF 3.9 4区 医学
Neurologia Pub Date : 2023-08-06 DOI: 10.1016/j.nrl.2022.11.003
J.M. Fernández-Vidal , M. Guasch Jiménez , I. Ruiz Barrio , B. Gómez-Ansón , M. Tecame , J. Martí-Fàbregas
{"title":"Basilar web y fenestración basilar; a propósito de un caso","authors":"J.M. Fernández-Vidal ,&nbsp;M. Guasch Jiménez ,&nbsp;I. Ruiz Barrio ,&nbsp;B. Gómez-Ansón ,&nbsp;M. Tecame ,&nbsp;J. Martí-Fàbregas","doi":"10.1016/j.nrl.2022.11.003","DOIUrl":"10.1016/j.nrl.2022.11.003","url":null,"abstract":"","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":"39 2","pages":"Pages 209-210"},"PeriodicalIF":3.9,"publicationDate":"2023-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0213485323000245/pdfft?md5=06bd20fce445f2091611899935a798ce&pid=1-s2.0-S0213485323000245-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43068256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calidad de vida y salud mental en el ictus juvenil 青年中风患者的生活质量与心理健康
IF 3.9 4区 医学
Neurologia Pub Date : 2023-08-01 DOI: 10.1016/j.nrl.2022.11.006
D. Alonso Modino, L. Perestelo Pérez, F. M. Rosa González, A. Toledo Chávarri, C. Valcarcel Nazco, F. Montón Álvarez
{"title":"Calidad de vida y salud mental en el ictus juvenil","authors":"D. Alonso Modino, L. Perestelo Pérez, F. M. Rosa González, A. Toledo Chávarri, C. Valcarcel Nazco, F. Montón Álvarez","doi":"10.1016/j.nrl.2022.11.006","DOIUrl":"https://doi.org/10.1016/j.nrl.2022.11.006","url":null,"abstract":"","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43675963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Baja frecuencia del estado epiléptico no convulsivo en la edad pediátrica: ¿mito o realidad? 小儿非惊厥性癫痫状态低频:神话还是现实?
IF 3.9 4区 医学
Neurologia Pub Date : 2023-08-01 DOI: 10.1016/j.nrl.2023.04.001
M. León-Ruiz, J. Benito-León, C. Castañeda-Cabrero
{"title":"Baja frecuencia del estado epiléptico no convulsivo en la edad pediátrica: ¿mito o realidad?","authors":"M. León-Ruiz, J. Benito-León, C. Castañeda-Cabrero","doi":"10.1016/j.nrl.2023.04.001","DOIUrl":"https://doi.org/10.1016/j.nrl.2023.04.001","url":null,"abstract":"","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43931462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estudio de la situación actual del Teleictus en España 研究西班牙Teleictus的现状
IF 3.9 4区 医学
Neurologia Pub Date : 2023-08-01 DOI: 10.1016/j.nrl.2023.05.003
A. Barragán-Prieto, S. Pérez-Sánchez, M. Castellanos, A. González, J. Montaner
{"title":"Estudio de la situación actual del Teleictus en España","authors":"A. Barragán-Prieto, S. Pérez-Sánchez, M. Castellanos, A. González, J. Montaner","doi":"10.1016/j.nrl.2023.05.003","DOIUrl":"https://doi.org/10.1016/j.nrl.2023.05.003","url":null,"abstract":"","PeriodicalId":19300,"journal":{"name":"Neurologia","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44375680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信